For the eleventh year in a row SwedenBIO presented the Pipeline Report 2016 in December. The report gives a view over the Swedish companies that are developing new medicines focusing on their projects. New for this year is that preclinical projects are included in the report. We had a chat with Sara Gunnerås, editor of the report.
Sara Gunnerås
Director of EU Support Office (EUSO) & Editor The Swedish Drug Discovery & Development Pipeline, SwedenBIO